The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Syros Pharmaceuticals, Inc(NASDAQ:SYRS) 
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are SY-1425, a selective retinoic acid receptor alpha agonist, which is in Ph...
Website: http://www.syros.com
Founded: 2011
Full Time Employees: 83
Sector: Healthcare
Industry: Biotechnology
Syros Pharmaceuticals Days Payable Outstanding ttm (DPO)
Syros Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Syros Pharmaceuticals Op Cashflow Per Share ttm
Syros Pharmaceuticals Free Cashflow Per Share ttm
Syros Pharmaceuticals Cash Per Share ttm
Syros Pharmaceuticals P/S ratio ttm
Syros Pharmaceuticals (GAAP) P/E ratio ttm
Syros Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.